drj logo
  • This field is for validation purposes and should be left unchanged.

Already have an account? Log in

drj logo

Welcome to DRJ

Already registered user? Please login here

Login Form

Register
Forgot password? Click here to reset

Create new account
(it's completely free). Subscribe

Skip to content
Disaster Recovery Journal
  • EN ESPAÑOL
  • SIGN IN
  • SUBSCRIBE
  • THE JOURNAL
    • Digital Edition
    • Article Submission
    • DRJ Annual Resource Directories
    • Article Archives
    • Career Spotlight
  • EVENTS
    • DRJ Spring 2023
    • DRJ Fall 2023
    • Other Industry Events
    • Schedule & Archive
  • WEBINARS
    • Upcoming Webinars
    • On Demand
  • MENTOR PROGRAM
  • DRJ ACADEMY
    • DRJ Academy
    • Beginner’s Guide to BC
  • RESOURCES
    • New to Business Continuity?
    • White Papers
    • DR Rules and Regs
    • Planning Groups
    • Business Directory
    • Business Resilience Decoded
    • DRJ Glossary of Business Continuity Terms
    • Careers
  • ABOUT
    • Advertise with DRJ
    • Board and Committees
      • Executive Council Members
      • Editorial Advisory Board
      • Career Development Committee
      • Glossary Committee
      • Rules and Regulations Committee
  • Podcast

Pharma’s Vaccine Tech Hoarding Kills, says AHF

by DRJ Editorial Team | November 11, 2022 | | 0 comments

LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) condemned today as criminal big pharma’s meddling in the World Trade Organization’s TRIPS waiver proposal negotiations, which would have allowed more countries to produce COVID-19 vaccines.

According to POLITICO, “Between January 2020 and September 2022, 13 pharmaceutical lobby groups and companies held nearly 100 meetings with the most senior [European] Commission officials. In the U.K., there were more than 360 meetings between January 2020 and March 2022 — equivalent to nearly one every two days.” Conversely, civil society groups advocating for vaccine equity only met with EC officials about 60 times and had only 20 U.K. meetings. From 2020 to 2021, big pharma and the largest lobbying groups spent over €30.7 million to lobby the EU during the pandemic.

“We knew the pharmaceutical industry – namely the big three COVID-19 vaccine makers, Johnson & Johnson, Pfizer, and Moderna – had a stranglehold on politicians globally, but this investigation reveals just how far they’ll go to put profits over people’s lives. The only word to describe it is ‘disgusting,’” said AHF President Michael Weinstein. “We, along with other vaccine equity advocates, condemn big pharma for their manipulative tactics to force countries to choose between lifesaving medicines or their economies taking a financial hit by drug companies threatening to withdraw investments. It’s despicable behavior, and we urge governments to address this conduct immediately as a threat to national and global health security – particularly during crises like the COVID-19 pandemic.”

AHF has advocated for vaccine equity since the start of the pandemic, including holding multiple protests at the headquarters of Pfizer, Moderna, and J&J. Numerous AHF country teams also delivered letters to the embassies of rich countries in an effort to garner support for the WTO’s TRIPS waiver proposal.

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

Contacts

US MEDIA CONTACT:

Ged Kenslea, Senior Director, Communications, AHF

+1 323 308 1833 work +1.323.791.5526 mobile

gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF

+1 323.308.1829

denys.nazarov@aidshealth.org

Related Content

  1. Disaster Recovery Journal
    A Lot of People are Talking About Measles: Are You?
  2. Career Spotlight – Vicky McKim
  3. Today’s Challenges Are Driving Big Changes in BCM

Recent Posts

Klaviyo Releases Q4 2022 Business Trend Recap

January 27, 2023

Versa Networks Hosting Versatility 2023 Annual User Conference Next Month

January 27, 2023

Renesas Receives “AA” MSCI ESG Rating for the First Time

January 27, 2023

FLEETCOR® Appoints Accomplished Technology Executive To Its Board of Directors

January 27, 2023

FiscalNote Announces Acquisition of Dragonfly, a Leading Geopolitical Data and Security Intelligence Company for Business Risk Decision-Makers at Blue-Chip Organizations Around the World

January 27, 2023

Real Matters Reports First Quarter Financial Results

January 27, 2023

Archives

  • January 2023 (1200)
  • December 2022 (1144)
  • November 2022 (1595)
  • October 2022 (1574)
  • September 2022 (1571)
  • August 2022 (1581)
  • July 2022 (1365)
  • June 2022 (1711)
  • May 2022 (1651)
  • April 2022 (1618)
  • March 2022 (1924)
  • February 2022 (1549)
  • January 2022 (1472)
  • December 2021 (1446)
  • November 2021 (1835)
  • October 2021 (1777)
  • September 2021 (1697)
  • August 2021 (1661)
  • July 2021 (1566)
  • June 2021 (1768)
  • May 2021 (1666)
  • April 2021 (1798)
  • March 2021 (1907)
  • February 2021 (1038)
  • January 2021 (554)
  • December 2020 (30)
  • November 2020 (35)
  • October 2020 (48)
  • September 2020 (57)
  • August 2020 (52)
  • July 2020 (40)
  • June 2020 (72)
  • May 2020 (46)
  • April 2020 (59)
  • March 2020 (46)
  • February 2020 (28)
  • January 2020 (36)
  • December 2019 (22)
  • November 2019 (11)
  • October 2019 (36)
  • September 2019 (44)
  • August 2019 (77)
  • July 2019 (117)
  • June 2019 (106)
  • May 2019 (49)
  • April 2019 (47)
  • March 2019 (24)
  • February 2019 (37)
  • January 2019 (12)
  • ARTICLES & NEWS

    • Business Continuity
    • Disaster Recovery
    • Crisis Management & Communications
    • Risk Management
    • Article Archives
    • Industry News

    THE JOURNAL

    • Digital Edition
    • Advertising & Media Kit
    • Submit an Article
    • Career Spotlight

    RESOURCES

    • White Papers
    • Rules & Regulations
    • FAQs
    • Glossary of Terms
    • Industry Groups
    • Business & Resource Directory
    • Business Resilience Decoded
    • Careers

    EVENTS

    • Spring 2023

    WEBINARS

    • Watch Now
    • Upcoming

    CONTACT

    • Article Submission
    • Media Kit
    • Contact Us

    ABOUT DRJ

    Disaster Recovery Journal is the industry’s largest resource for business continuity, disaster recovery, crisis management, and risk management, reaching a global network of more than 138,000 professionals. Offering weekly webinars, the latest industry news, rules and regulations, podcasts, the industry’s only official mentoring program, a quarterly magazine, and two annual live conferences, DRJ is leading the way to keep professionals up-to-date and connected in an ever-changing world.

    LEARN MORE

    TWITTER

    Disaster Recovery Journal is the leading publication/event covering business continuity/disaster recovery.

    Follow us for daily updates @drjournal

    Newsletter

    The Journal, right in your inbox.

    Be informed and stay connected by getting the latest in news, events, webinars and whitepapers on Business Continuity and Disaster Recovery.

    Subscribe Now
    Copyright 2023 Disater Recovery Journal
    • Terms of Use
    • Privacy Policy